Recombinant human erythropoietin delays loss of gray matter in chronic schizophrenia
Molecular Psychiatry2010Vol. 16(1), pp. 26–36
Citations Over TimeTop 10% of 2010 papers
Torsten Wüstenberg, Martin Begemann, Claudia Bartels, Olaf Gefeller, Sabina Stawicki, Dunja Hinze‐Selch, Alexander Mohr, Peter Falkai, J. Aldenhoff, Michael Knauth, Klaus-Armin Nave, Hannelore Ehrenreich
Related Papers
- → Erythropoietin neuroprotection with traumatic brain injury(2012)80 cited
- → Second-generation non-hematopoietic erythropoietin-derived peptide for neuroprotection(2021)20 cited
- → Erythropoietin in neonatal brain protection: The past, the present and the future(2010)65 cited
- → Neuroprotective Effects of an Erythropoietin-Derived Peptide in PC1 2 Cells under Oxidative Stress(2016)11 cited
- [Progress on neuroprotective effects of erythropoietin].(2013)